LAZARD ASSET MANAGEMENT LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1207017 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$943,205

+$51,183 QoQ

Shares Held

37,178

-5.8% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#93

of 254 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names. PCRX ranks #10 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	945,784	$67,964,038
2	RDY	Dr Reddys Laboratories Ltd	1,231,678	$17,847,014
3	NBIX	Neurocrine Biosciences Inc	91,371	$15,399,668
4	KNSA	Kiniksa Pharmaceuticals International, plc	67,291	$4,303,259
5	PAHC	Phibro Animal Health Corp	130,438	$4,095,753
6	LNTH	Lantheus Holdings, Inc.	34,396	$3,815,892
7	ELAN	Elanco Animal Health Inc	95,219	$2,343,339
8	TLRY	Tilray Brands, Inc.	394,715	$1,772,270

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$943,205	37,178	-5.8%	Shares	Sole	2026-08-14
2026-03-31	$892,022	39,470	+5.8%	Shares	Sole	2026-05-15
2025-12-31	$965,349	37,301	-11.7%	Shares	Sole	2026-02-17
2025-09-30	$1,088,988	42,258	-29.4%	Shares	Sole	2025-11-14
2025-06-30	$1,430,724	59,863	-60.4%	Shares	Sole	2025-08-14
2025-03-31	$3,753,044	151,028	+247.3%	Shares	Sole	2025-05-15
2024-12-31	$819,369	43,491	+4122.4%	Shares	Sole	2025-02-14
2023-09-30	$31,600	1,030	-33.3%	Shares	Sole	2023-11-14
2023-03-31	$63,010	1,544	-53.0%	Shares	Sole	2023-05-15
2022-03-31	$250,482	3,282	-16.6%	Shares	Sole	2022-05-13
2021-12-31	$236,708	3,934	+7.9%	Shares	Sole	2022-02-09
2020-06-30	$191,253	3,645	-12.5%	Shares	Sole	2020-08-13
2020-03-31	$139,753	4,168	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.